September 25, 2020 — Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 (SARS-CoV-2) who are risk assessed prior to receiving the drug. That is the finding of research published today in EP Europace, a journal of the European Society of Cardiology (ESC).[1]  

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE. 

September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use system provides an all-in-one aspiration pump and catheter for the removal of blood clots from the vessels of the peripheral arterial and venous systems. The system’s innovative all-in-one design is simple to use while eliminating the need for capital equipment or costly accessories, with easy setup supporting faster procedures times.

Adult Congenital heart Symposium — Houston Methodist

Adult Congenital heart Symposium — Houston Methodist
DATE: Saturday, November 7, 2020
TIME: 7:50 am – 2:00 pm
FORMAT: Virtual Conference

REGISTRATION: https://events.houstonmethodist.org/achsymposium

COURSE DIRECTOR: C. Huie Lin, MD, PhD, Director, Adult Congenital Heart Program, Houston Methodist

Vascular Ultrasound Master Class — Houston Methodist

DATE: Saturday, October 24, 2020
TIME: 8:15 am – 2:00 pm
FORMAT: Virtual Conference

REGISTRATION: https://events.houstonmethodist.org/vascularultrasoundmc

COURSE DIRECTOR: Alan B. Lumsden, MD, Walter W. Fondren III Presidential Distinguished Chair, DeBakey Heart & Vascular Center, Chair, Department of Cardiovascular Surgery, Professor of Cardiovascular Surgery, Academic Institute, Full Clinical Member, Research Institute, Houston Methodist, Weill Cornell Medical College

CVD Prevention Symposium — Houston Methodist

DATE: Saturday, October 3, 2020
TIME: 8:00 am – 12:30 pm
FORMAT: Virtual Conference

REGISTRATION: https://events.houstonmethodist.org/CVD-Prevention

COURSE DIRECTOR: Khurram Nasir, MD, MPH, Co-director, Center for Outcomes Research, Houston Methodist

September 25, 2020 — Based on its recent analysis of the global artificial intelligence (AI)-based echocardiography market, Frost & Sullivan recognizes Ultromics with the 2020 Global New Product Innovation Award for enhancing diagnostic quality in cardiac care units with its AI suite, Ech

September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary artery calcium (CAC) computed tomography (CT) imsging screening resulted in an immediate increase in utilization of the test. Furthermore, no-charge calcium screening was associated with an increase in representation by women, minorities and people living in ZIP codes with lower income. These findings strongly suggest that removing the cost burden will result in widespread use of CAC screening for cardiovascular risk assessment, especially in traditionally underserved groups.

September 24, 2020 — Analyzing anonymized patient medical records, University of California (UC) San Diego Health researchers discovered that cholesterol-lowering statins reduced risk of severe COVID-19 (SARS-CoV-2) infection, while lab experiments uncovered a cellular mechanism that helps explain why.

September 24, 2020 — Fitbit received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the European Union, for its electrocardiogram (ECG) app to assess heart rhythm for atrial fibrillation (AFib). The arrhythmia is a condition that affects more than 33.5 million people globally.[1]

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now